Answers are grounded in this paper and cite their sources.
In-vitro analysis shows that rutin increases coagulation times in human blood, suggesting its potential as a natural anticoagulant.
Background Rutin is a plant-derived flavonoid with reported biological activities, but its effect on blood coagulation parameters has not been clearly characterized under in-vitro conditions. Objective This study aimed to evaluate the in-vitro anticoagulant activity of rutin in human blood by measuring changes in clotting time (CT), prothrombin time (PT), and activated partial thromboplastin time (aPTT) at increasing concentrations, compared with baseline control values. Materials and Methods Rutin (1-6 mg/mL) was added to human blood samples, and standard CT, PT, and aPTT assays were used to measure coagulation parameters. Heparin and Phosphate-buffered saline (PBS) were used as controls. Results In a concentration-dependent manner, rutin significantly increased activated partial thromboplastin time (aPTT), prothrombin time (PT), and clotting time (CT) compared with the PBS control, with the most pronounced effects observed at higher concentrations (4 and 6 mg/mL; P < 0.05 vs control). At 6 mg/mL, CT increased to 11.42 ± 1.11 minutes, PT to 21.33 ± 3.28 seconds, and aPTT to 57.20 ± 9.31 seconds. Conclusion Rutin exhibits significant in vitro anticoagulant activity, supporting its potential as a natural anticoagulant candidate.
No takes yet. Share an insight, caveat, or question.
Palikhey et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: